Their research has found out not only elevated levels of ox-LDL in primary and metastatic PCa, but also an increased proliferation, migration, and invasion rate of prostate cancer cells, mediated by ox-LDL through OLR1. These results make ox-LDL a hallmark of PCa progression and prognosis. The gene discussed is OLR1; the disease is prostate carcinoma.